Status:
UNKNOWN
Study on Skin Microbiome of HFS
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University
Collaborating Sponsors:
Sponsor GmbH
Conditions:
Microbiota
Eligibility:
FEMALE
18-65 years
Brief Summary
To skin microecology and breast cancer chemotherapy drug therapy as the breakthrough point, disease prevention and treatment of breast cancer in China, the important scientific problems in basic resea...
Detailed Description
To skin microecology and breast cancer chemotherapy drug therapy as the breakthrough point, disease prevention and treatment of breast cancer in China, the important scientific problems in basic resea...
Eligibility Criteria
Inclusion
- age: 18-65 years old
- advanced breast cancer patients
- healthy volunteers
Exclusion
- previous skin disease history, or other skin disease activity at present
- various antibiotics, prebiotics, probiotics or lactic acid products used within three months;
- having a history of alcoholism for more than 2 years and smoking for years;
- pregnancy or lactation;
- have oral, respiratory and gastrointestinal diseases;
- other metabolic diseases, such as obesity, hypertension, diabetes, stones, and liver diseases;
- other autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease;
- history of gastrointestinal surgery;
- family genetic history, history of mental illness, etc.;
- the subject is participating in other research projects;
- other reasons are not considered suitable for continued clinical trials.
Key Trial Info
Start Date :
September 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04132713
Start Date
September 10 2019
End Date
October 15 2020
Last Update
October 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First affiliated hospital of Harbin medical university
Harbin, Heilongjiang, China, 150001